Adoptive cell therapy for solid tumors: Chimeric antigen receptor T cells and beyond

被引：17
|
作者：
Moreno, Victor [1 ]
Hernandez, Tatiana [1 ]
de Miguel, Maria [2 ]
Doger, Bernard [1 ]
Calvo, Emiliano [2 ]
机构：
[1] Hosp Univ Fdn Jimenez Diaz, Start Madrid FJD, Madrid, Spain
[2] START Madrid CIOCC Ctr Integral Oncol Clara Campa, Madrid, Spain
来源：
CURRENT OPINION IN PHARMACOLOGY | 2021年 / 59卷
关键词：
PHASE-I; INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; ANTITUMOR-ACTIVITY; COMPLETE RESPONSES; SUICIDE-GENE; IMMUNOTHERAPY; LEUKEMIA; TRIAL; HER2;
D O I：
10.1016/j.coph.2021.05.004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Adoptive cell therapy with chimeric antigen receptor T cells has caused a significant revolution in the treatment of hematological malignancies. Unfortunately, for solid tumors, this treatment modality has been proven insufficient to achieve significant antitumor activity. The use of modified T cell receptors towards tumor-associated antigens (NY-ESO, MAGE-A4) has recently shown antitumor activity in synovial sarcoma. Also, treatment with tumor-infiltrating lymphocytes shows clinical activity in metastatic cervical cancer and melanoma resistant to checkpoint inhibitors. Strategies to improve results and broaden the applicability of therapeutic lymphocytes for solid tumors include local delivery, fourth generation chimeric antigen receptor T cells, off-the-shelf T lymphocytes and private neoantigen-directed cells, among others. In this review, we summarize the status of adoptive cell therapy using T cells for solid tumors and the investigational strategies being tested in this field.
引用
收藏
页码：70 / 84
页数：15
相关论文
共 50 条
  • [21] How Do We Meet the Challenge of Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors?
    Schoenfeld, Adam J.
    O'Cearbhaill, Roisin E.
    CANCER JOURNAL, 2021, 27 (02) : 134 - 142
  • [22] Is adoptive T-cell therapy for solid tumors coming of age?
    Pedrazzoli, P.
    Comoli, P.
    Montagna, D.
    Demirer, T.
    Bregni, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 (08) : 1013 - 1019
  • [23] The Weal and Woe of Costimulation in the Adoptive Therapy of Cancer with Chimeric Antigen Receptor (CAR)-Redirected T Cells
    Hombach, A. A.
    Holzinger, A.
    Abken, H.
    CURRENT MOLECULAR MEDICINE, 2013, 13 (07) : 1079 - 1088
  • [24] Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities
    Xia, An-Liang
    Wang, Xiao-Chen
    Lu, Yi-Jun
    Lu, Xiao-Jie
    Sun, Beicheng
    ONCOTARGET, 2017, 8 (52): : 90521 - 90531
  • [25] Do CARs Need a Driver's License? Adoptive Cell Therapy with Chimeric Antigen Receptor-Redirected T Cells Has Caused Serious Adverse Events
    Buening, Hildegard
    Uckert, Wolfgang
    Cichutek, Klaus
    Hawkins, Robert E.
    Abken, Hinrich
    HUMAN GENE THERAPY, 2010, 21 (09) : 1039 - 1042
  • [26] Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors
    Jin, Chuan
    Yu, Di
    Essand, Magnus
    IMMUNOTHERAPY, 2016, 8 (12) : 1355 - 1361
  • [27] Challenges and interventions of chimeric antigen receptor-T cell therapy in solid tumors
    Liu, Shasha
    Zhang, Yi
    CHINESE JOURNAL OF CANCER RESEARCH, 2023, 35 (03) : 239 - 244
  • [28] Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure
    Holland, Elizabeth M.
    Yates, Bonnie
    Steinberg, Seth M.
    Yuan, Constance M.
    Wang, Hao-Wei
    Annesley, Colleen
    Shalabi, Haneen
    Stroncek, David
    Fry, Terry J.
    Krueger, Joerg
    Jacoby, Elad
    Hsieh, Emily
    Bhojwani, Deepa
    Gardner, Rebecca A.
    Maude, Shannon L.
    Shah, Nirali N.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (09): : 574.e1 - 574.e10
  • [29] Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
    Zhang, Erhao
    Gu, Jieyi
    Xu, Hanmei
    MOLECULAR CANCER, 2018, 17
  • [30] Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies
    Heyman, Benjamin
    Yang, Yiping
    CANCERS, 2019, 11 (02):
12345